Tong Pang Selected Research

Neoplasm Metastasis (Metastasis)

9/2022

A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong Pang Research Topics

Disease

2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 01/2021
1	Neoplasm Metastasis (Metastasis) 09/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2021
1	Neoplasms (Cancer) 07/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Infections 01/2011

Drug/Important Bio-Agent (IBA)

2	Tyrosine Kinase InhibitorsIBA 09/2022 - 01/2021
2	osimertinibIBA 09/2022 - 01/2021
1	ErbB Receptors (EGF Receptor)IBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	AfatinibIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	PlastoquinoneIBA 01/2011
1	Oxygen (Dioxygen)IBA 01/2011

Therapy/Procedure

1	Immunotherapy 07/2021
1	Therapeutics 01/2021
1	Nephrectomy 01/2021